Volv has unique capabilities and technologies aiming at closing the diagnostic gap in rare diseases in many different countries.
Volv is excited to announce its involvement in a programme produced by Genetic Alliance UK and ITN Business.
Anchored by journalist and presenter Hannah Vaughan Jones from the ITN London studio, the programme looks at how rare conditions can be complex and life limiting, often with a long diagnostic journey and delayed treatment.
With advanced technology, genetic science, treatment and management – 𝗧𝗢𝗚𝗘𝗧𝗛𝗘𝗥 caring for rare disease – can make all the difference.
In the video, featuring Volv Global SA, the company explains what they do to help closing the diagnostic gap, accelerating a patient’s access to treatment, and improving the outcome of those living with rare disease, such as Fabry and Pompe disease.
